1911 Gold Announces C$11.5 Million “Bought Deal” Life Offering and Private Placement
1911 Gold Corporation (‘ 1911 Gold ‘ or the ‘ Company ‘) (TSXV: AUMB; FRA: 2KY) is pleased to announce that it
How to Use Fibonacci Retracements to Spot Key Levels
Join Dave as he shares how he uses the power of Fibonacci retracements to anticipate potential turning points. He takes viewers through
‘I started to feel numb’: Woman recalls syringe attack at French music festival
It was around 1.30 a.m., after the crowds had thinned
Offense vs. Defense: How Geopolitical Tensions Shape Market Trends
As the cycle of uncertainty continues to yield confusion than clarity, investors are again caught having to decide between taking an offensive
Israel agreed to a ceasefire with Iran. Could Gaza be next?
After 12 days of intense strikes between Israel and Iran
How Fanatics is teaching business acumen to pro athletes
Sports merchandising giant Fanatics is aiming to build a training camp for athletes to prepare them for life off the field. More than
Russian attacks kill dozens of Ukrainians as Kyiv’s allies gather for a key NATO summit
Russia killed dozens of Ukrainian civilians in less than 48
Bold Ventures Announces Closing of Its Fully Subscribed, Upsized Non-Brokered Private Placement
Bold Ventures Inc. (TSXV: BOL) (the ‘Company’ or ‘Bold’) is pleased to announce the fourth and final closing of its non-brokered private placement
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹?¹Tb-KLK3-mAb Phase I Clinical Trial in Australia
RAD 402 preclinical data package complete; demonstrates safety and promising biodistribution profile Ethics approval and Phase 1 clinical trial start